AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studySystematic reviewPeer review unconfirmed
Human DNA Methylation and Multiple Sclerosis
A systematic review highlights that DNA methylation plays a role in genetic risk for multiple sclerosis (MS), with unique epigenetic signatures in immune cells tied to disease processes and progression.
- Tags
- #MSResearch
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not yet assessed
- Mechanism
- Not yet assessed
- Evidence strength
- Not yet assessed
- Outcome
- Not yet assessed
Why it matters
These findings provide insights into MS mechanisms, potentially aiding in the development of new diagnostic and prognostic tools, which could improve patient care.
What this does not prove
The review does not establish specific causal relationships between DNA methylation and MS due to its systematic nature.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceEpigenetic mechanisms in neuroinflammatory disease of the brain: Multiple sclerosis. ↗DOI: 10.1016/b978-0-443-19043-8.00007-4
Supporting passages (4)
study designIn this chapter, we review the key findings from epigenetic studies, with a focus on the most studied modification, that is, DNA methylation.
subjectsUtilization of causal analytic approaches in large cohorts provides evidence that DNA methylation mediates genetic risk in MS.
findingsThe outcomes of epigenetic studies provide complementary mechanistic insights into the disease initiation and progression, and might aid a better understanding of the mechanisms underpinning the disease trajectory, development of novel diagnostic and prognostic biomarkers, and ultimately improving the care of people with MS.
limitationsTitle: Epigenetic mechanisms in neuroinflammatory disease of the brain: Multiple sclerosis.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.